| Followers | 227 |
| Posts | 13630 |
| Boards Moderated | 0 |
| Alias Born | 03/15/2013 |
Wednesday, September 27, 2023 5:33:22 PM
27k shares waiting on the buyout news! Happy early retirement all over again
$$$$$$
$$$$$$
Recent ACAD News
- Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer • Business Wire • 07/06/2026 01:04:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2026 10:00:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/26/2026 07:09:55 PM
- DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP • Business Wire • 06/26/2026 10:49:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/10/2026 08:05:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/02/2026 08:32:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/01/2026 10:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 08:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/27/2026 10:00:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/26/2026 08:02:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:50:28 PM
- Acadia Pharmaceuticals Reports First Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance • Business Wire • 05/06/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 10:00:18 PM
- Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career • Business Wire • 04/30/2026 08:05:00 PM
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences • Business Wire • 04/28/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/28/2026 07:53:50 PM
- Acadia Pharmaceuticals to Present Data at the 2026 American Academy of Neurology (AAN) Annual Meeting • Business Wire • 04/17/2026 01:05:00 PM
- Acadia Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026 • Business Wire • 04/15/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 11:57:16 PM
